Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)

Clinical trial NCT07216859 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07216859
Sponsor: Kaiser Permanente
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease Cirrhosis

Start date: 2028-01-01
Primary completion: 2028-11-01
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.